[CH3:1][O:2][C:3]1[CH:12]=[C:11]([NH:13][C:14](=[O:16])[CH3:15])[C:10]([Cl:17])=[CH:9][C:4]=1[C:5]([O:7]C)=O.C1(C)C(C)=CC=CC=1.[CH:26]1([CH2:32][N:33]2[CH2:38][CH2:37][CH:36]([NH2:39])[CH2:35][CH2:34]2)[CH2:31][CH2:30][CH2:29][CH2:28][CH2:27]1.CC(C)[O-].[Al+3].CC(C)[O-].CC(C)[O-]>CO>[CH:26]1([CH2:32][N:33]2[CH2:38][CH2:37][CH:36]([NH:39][C:5](=[O:7])[C:4]3[CH:9]=[C:10]([Cl:17])[C:11]([NH:13][C:14](=[O:16])[CH3:15])=[CH:12][C:3]=3[O:2][CH3:1])[CH2:35][CH2:34]2)[CH2:27][CH2:28][CH2:29][CH2:30][CH2:31]1A mixture of methyl 2-methoxy-4-acetamido-5-chlorobenzoate (25.7 g; 0.1 moles), xylene (80 ml), 1-cyclohexylmethyl-4-aminopiperidine (21.6 g; 0.11 moles) and aluminium isopropoxide (5 g) was heated to the boiling point whilst methanol was distilled off as it was formed. When the theoretical quantity of methanol was removed, the xylene was distilled off and the residue was dissolved in 2 N hydrochloric acid (200 ml). The aqueous solution was made alkaline with sodium hydroxide solution, extracted with chloroform and the chloroformic layer evaporated to dryness to give N-(1-cyclohexylmethylpiperid-4-yl)-2-methoxy-4-acetamido-5-chlorobenzamide (27 g). Its hydrochloride monohydrate was prepared by the procedure described in Example 2, m.p. 219°-221° C.